TransEnterix Revenue and Competitors
Estimated Revenue & Valuation
- TransEnterix's estimated annual revenue is currently $2.4M per year.
- TransEnterix received $40.0M in venture funding in May 2018.
- TransEnterix's estimated revenue per employee is $9,796
- TransEnterix's total funding is $427.9M.
- TransEnterix has 245 Employees.
- TransEnterix grew their employee count by 8% last year.
What Is TransEnterix?
TransEnterix® Surgical, Inc. (NYSE:TRXC), headquartered in Morrisville, North Carolina, is advancing surgery through innovation®. Our vision is to improve clinical outcomes and patient care through the use of robotics in surgery. We are focused on the commercialization of the Senhance Surgical System. Senhance has been granted a CE Mark and is available for sale in the United States. For a complete list of indications for use, please visit: https://www.transenterix.com/indications-for-use/keywords:Healthcare
Number of Employees
Employee Growth %
... Johnson and Johnson, Aspire Bariatrics, GI Dynamics, TransEnterix, USGI Medical, Apollo Endosurgery, Olympus, Mediflex Surgical Product.
Intuitive Surgical, Titan Medical, TransEnterix, AVRA Surgical Robotics, NovaTract Surgical. This comprehensive Gynecology Robotic Surgery...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Feb 23, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to A ...
Shares of TransEnterix (NYSE:TRXC) started inching back up this morning following a nearly 33% plunge yesterday fueled by disappointing second-quarter results. The Research Triangle Park, N.C.-based company posted losses of $20.1 million, or -10¢ per share, on sales of $3.64 million for the thr ...
TransEnterix (TRXC -17.6%) is down on below-average volume in response to its public offering of 28M common shares that it expects to ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|2016-12-22||$25.0M||Undisclosed||Lincoln Park Capital||Article|
|2018-05-25||$40.0M||Undisclosed||Hercules Capital Inc||Article|